Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
1. TEVA shares fell 13% to $18.78 after Q4 results. 2. U.S. crude inventories rose more than expected, impacting oil prices. 3. Consumer staples increased by 0.7%, contrasting tech's 1.9% decline.